3185 results for «600082»
3185 results
Imaging-guided intravascular lithotripsy for calcified lesions - LIVE case
27 Feb 2026 – From Euro4C Annual Meeting 2026
This live educational case from St. Francis Hospital and Heart Center demonstrates imaging-guided intravascular lithotripsy for calcified lesions. It covers lesion selection criteria, preparation and delivery of lithotripsy catheters, and reviews recent clinical evidence to guide best practices.
LIVE Educational Case from St. Francis Hospital & Heart...
Hostile access for TAVI procedure
21 May 2025 – From EuroPCR 2025
This session addresses the challenges of hostile vascular access in TAVI procedures. Learn to identify difficult access sites through pre-operative imaging, explore alternative approaches such as axillary access, techniques to overcome iliac access difficulties, and management of peri- and post-operative complications by vascular surgeons.
Techniques and decision making in management of coronary bifurcation lesion
20 May 2025 – From EuroPCR 2025
Explore advanced techniques and decision-making processes in managing coronary bifurcation lesions. This session covers high-risk PCI in calcified left main bifurcations, distal wire anchoring for angulated vessels, and the use of drug-coated balloons to simplify complex ostial lesions, providing valuable insights for optimizing bifurcation PCI outcomes.
TEER for challenging anatomy: from myth to reality
21 May 2025 – From EuroPCR 2025
Explore advanced TEER techniques for challenging anatomies. This session covers indications, periprocedural steps, state-of-the-art procedural methods, and management of failed surgical tricuspid annuloplasty, with case discussions highlighting practical learnings for complex mitral and tricuspid interventions.
Complex PCI for stent failure: LIVE Educational Case from Hospital Clínico San Carlos - Madrid, Spain
21 May 2025 – From EuroPCR 2025
This live educational case from Hospital Clínico San Carlos, Madrid, offers an in-depth look at complex PCI for stent failure. Learn how intracoronary imaging identifies failure mechanisms, guides treatment of recurrent restenosis, and explores drug-coated balloon options to optimize patient outcomes.
Treatment and prognostic stratification of ACS patients with cardiogenic shock
21 May 2025 – From EuroPCR 2025
This session focuses on treatment and prognostic stratification in ACS patients complicated by cardiogenic shock. Topics include mechanical CPR device performance, SCAI shock grade dynamics, hemorrhagic event predictors, ECMO-related strategies, and evaluation of BCIS conveyance algorithms for out-of-hospital cardiac arrest.
When multivessel disease is so complex
21 May 2025 – From EuroPCR 2025
Addressing the complexities of multivessel coronary disease, this session presents challenging cases including double chronic total occlusions and the emerging link between blood lipids and plaque formation. Learn strategic approaches to revascularization in NSTEMI and investigative insights into plaque biology.
Calcified nodules: a different beast?
21 May 2025 – From EuroPCR 2025
This session offers a comprehensive exploration of calcified nodules, a challenging entity in PCI. Learn to identify these nodules with IVUS and OCT, understand their unique treatment challenges, and select optimal plaque modification tools through detailed case discussions.
Management of stent-related complications
21 May 2025 – From EuroPCR 2025
This session addresses the management of stent-related complications through a series of dramatic clinical cases. Learn methodical approaches to routine and crisis scenarios including primary PCI complications, failure to stent, and unexpected challenges encountered during interventions, highlighting practical bailout techniques and decision-making frameworks.
TAV-in-TAV complications
21 May 2025 – From EuroPCR 2025
Focus on the complexities and challenges of TAV-in-TAV procedures in this session. Topics include planning valve-in-valve TAVI for aortic bioprosthetic valve regurgitation, managing anatomical challenges such as left ventricular outflow tract calcium and large annulus, and addressing severe bicuspid valve stenosis with impaired ventricular function. The...
Iatrogenic causes for shock treated with LV support
21 May 2025 – From EuroPCR 2025
Explore the management of iatrogenic causes of cardiogenic shock requiring left ventricular support. This session presents complex cases including shock following Bentall procedures, complications during anesthesia induction in bypass surgery, and strategic approaches to prevent and manage these critical scenarios using LV support devices.
Academic Research Consortium on LAA closure
21 May 2025 – From EuroPCR 2025
Gain comprehensive understanding of the Academic Research Consortium's achievements in left atrial appendage (LAA) closure. Learn how standardized endpoints are streamlined for randomized controlled trials and how collaborative efforts homogenize definitions to advance clinical research.
Primary PCI for STEMI – Optimising outcomes
21 May 2025 – From EuroPCR 2025
Optimize primary PCI outcomes for STEMI patients by integrating state-of-the-art techniques and coronary physiology insights. The session includes case discussions highlighting treatment strategies and key learnings to enhance clinical practice.
DES and DCB for bifurcation treatment
21 May 2025 – From EuroPCR 2025
Examine the use of drug-eluting stents (DES) and drug-coated balloons (DCB) in bifurcation lesion treatment. This session compares devices, analyses DAPT duration, and evaluates side branch optimization to inform best practices in bifurcation PCI.
Major Late-Breaking Trials from EuroPCR 2025
21 May 2025 – From EuroPCR 2025
Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...
Treatment dilemmas in STEMI patients with multivessel disease
21 May 2025 – From EuroPCR 2025
Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.
Stent technologies, last evidence in coronary interventions
21 May 2025 – From EuroPCR 2025
Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...
Case-based learning on different aspects of transcatheter LAA closure
21 May 2025 – From EuroPCR 2025
Engage in case-based learning focused on transcatheter left atrial appendage (LAA) closure. This session covers safe transseptal puncture techniques, state-of-the-art standard LAA closure procedures, management of challenging LAA anatomies, and optimization of post-procedure antithrombotic therapy in high-risk patients.
Choices, choices: a global perspective on multiple modalities for calcium modification
21 May 2025 – From EuroPCR 2025
Gain a global perspective on multiple modalities for calcium modification in coronary interventions. This session reviews comparative analyses of orbital, shockwave, rotational atherectomy, and cutting balloons, explores evolving rotational atherectomy practices in the era of intravascular lithotripsy, and presents preliminary data from international registries on coronary...
Novel devices for edge-to-edge mitral repair
21 May 2025 – From EuroPCR 2025
Discover novel devices advancing transcatheter edge-to-edge mitral valve repair (TEER). This session presents clinical experiences with cost-effective and uniquely designed TEER systems for patients with degenerative mitral regurgitation and heart failure, including first-in-man applications and case series demonstrating safety and efficacy.